Cited 0 times in
Prognostic reappraisal of postoperative carcinoembryonic antigen in T1-2N0 colorectal cancer
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Pian, G | - |
dc.contributor.author | Shin, JS | - |
dc.contributor.author | Yoon, S | - |
dc.contributor.author | Oh, SY | - |
dc.date.accessioned | 2023-01-05T03:03:51Z | - |
dc.date.available | 2023-01-05T03:03:51Z | - |
dc.date.issued | 2021 | - |
dc.identifier.issn | 0250-7005 | - |
dc.identifier.uri | http://repository.ajou.ac.kr/handle/201003/23794 | - |
dc.description.abstract | Background/Aim: The purpose of this study was to compare the prognostic value of preoperative carcinoembryonic antigen (CEA), preoperative CEA/tumor size and postoperative CEA in stage I colorectal cancer. Patients and Methods: We analyzed a total of 305 consecutive stage I colorectal cancer patients who underwent a radical surgery at our Department. The patients were divided into low and high preoperative CEA groups, low and high preoperative CEA/tumor size groups, and low and high postoperative CEA groups according to the optimal cut-off values. Results: Multivariate analysis showed that postoperative CEA was independently associated with OS and DFS. However, the preoperative CEA and preoperative CEA/tumor size were not. Conclusion: The prognostic value of postoperative CEA is better than preoperative CEA and preoperative CEA/tumor size in patients with stage I colorectal cancer. Moreover, the common 5 ng/ml cut-off was not optimal for risk stratification in stage I colorectal cancer. | - |
dc.language.iso | en | - |
dc.subject.MESH | Adult | - |
dc.subject.MESH | Aged | - |
dc.subject.MESH | Aged, 80 and over | - |
dc.subject.MESH | Biomarkers, Tumor | - |
dc.subject.MESH | Carcinoembryonic Antigen | - |
dc.subject.MESH | Colorectal Neoplasms | - |
dc.subject.MESH | Digestive System Surgical Procedures | - |
dc.subject.MESH | Female | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Male | - |
dc.subject.MESH | Middle Aged | - |
dc.subject.MESH | Multivariate Analysis | - |
dc.subject.MESH | Neoplasm Staging | - |
dc.subject.MESH | Prognosis | - |
dc.subject.MESH | Survival Analysis | - |
dc.subject.MESH | Treatment Outcome | - |
dc.subject.MESH | Tumor Burden | - |
dc.title | Prognostic reappraisal of postoperative carcinoembryonic antigen in T1-2N0 colorectal cancer | - |
dc.type | Article | - |
dc.identifier.pmid | 33517321 | - |
dc.subject.keyword | Colorectal cancer | - |
dc.subject.keyword | Postoperative CEA | - |
dc.subject.keyword | Preoperative CEA | - |
dc.subject.keyword | Preoperative CEA/tumor size | - |
dc.subject.keyword | Stage I | - |
dc.contributor.affiliatedAuthor | Shin, JS | - |
dc.contributor.affiliatedAuthor | Yoon, S | - |
dc.contributor.affiliatedAuthor | Oh, SY | - |
dc.type.local | Journal Papers | - |
dc.identifier.doi | 10.21873/ANTICANRES.14868 | - |
dc.citation.title | Anticancer research | - |
dc.citation.volume | 41 | - |
dc.citation.number | 2 | - |
dc.citation.date | 2021 | - |
dc.citation.startPage | 1101 | - |
dc.citation.endPage | 1110 | - |
dc.identifier.bibliographicCitation | Anticancer research, 41(2). : 1101-1110, 2021 | - |
dc.embargo.liftdate | 9999-12-31 | - |
dc.embargo.terms | 9999-12-31 | - |
dc.identifier.eissn | 1791-7530 | - |
dc.relation.journalid | J002507005 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.